e-Clinical Outcome Assessments Segment has the Largest Share of Type of Solution in the Middle East and Africa ePRO, ePatient Diaries, and eCOA Market during 2021-2028
According to this research study titled “Middle East and Africa ePRO, ePatient Diaries, and eCOA Market to 2028 - COVID-19 Impact and Regional Analysis and Forecast by Type of Solution, Modality, and End User,” the market is expected to reach US$ 112.3 million by 2028 from US$ 48.4 million in 2021. The market is estimated to grow at a CAGR of 12.8% from 2021 to 2028. The report provides trends prevailing in the Middle East and Africa ePRO, ePatient Diaries, and eCOA market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the increasing demand for electronic health records (EHRs), rising use of smartphones and growing demand for clinical trials are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the concerns regarding data privacy.
The COVID-19 pandemic has accelerated much-needed changes in clinical trial conduct, including an increase in the use of ePRO and other remote-assessment technologies. Sponsors and CROs have been using technology for various research activities, from patient consent and consultation to PROs and side monitoring, driven by the need to implement new methods for working and communicating with study participants.
The market for ePRO, ePatient Diaries, and eCOA market is segmented into type of solution, modality, and end user. In 2020, the eCOA (Electronic Clinical Outcome Assessments) segment accounted for the Middle East and Africa ePRO, ePatient diaries, and eCOA market's largest market share. This large share can be attributed to the advantages offered by eCOA, as eCOA uses technology such as smartphones, laptops, computers to enable patients, nurses, and doctors to consult directly about medical test results. ECOA provides highly accurate knowledge that better understands and simplifies the acceptance process for patient reviews in clinical trials. In addition, the increasing cost for pharmaceutical manufacturers of modern overall drug development methodologies has led to their use of electronic information collection by way of paper-based processes. Data processing across eCOA networks improves the quality of the information gathered, harmonizes data systems, and gives users valuable benefits, such as data interpretation.
The Diary Pte. Ltd, ICON PLC, PAREXEL INTERNATIONAL CORPORATION, Bracket Global LLC, Dassault Systèmes SE, and CRF Health are among the leading companies in the Middle East and Africa ePRO, ePatient Diaries, and eCOA market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, ERT, announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality, and data security.
The report segments the Middle East and Africa EPRO, ePatient Diaries, and eCOA market as follows:
By Type of Solution
By Modality
By End User
By Country
The COVID-19 pandemic has accelerated much-needed changes in clinical trial conduct, including an increase in the use of ePRO and other remote-assessment technologies. Sponsors and CROs have been using technology for various research activities, from patient consent and consultation to PROs and side monitoring, driven by the need to implement new methods for working and communicating with study participants.
The market for ePRO, ePatient Diaries, and eCOA market is segmented into type of solution, modality, and end user. In 2020, the eCOA (Electronic Clinical Outcome Assessments) segment accounted for the Middle East and Africa ePRO, ePatient diaries, and eCOA market's largest market share. This large share can be attributed to the advantages offered by eCOA, as eCOA uses technology such as smartphones, laptops, computers to enable patients, nurses, and doctors to consult directly about medical test results. ECOA provides highly accurate knowledge that better understands and simplifies the acceptance process for patient reviews in clinical trials. In addition, the increasing cost for pharmaceutical manufacturers of modern overall drug development methodologies has led to their use of electronic information collection by way of paper-based processes. Data processing across eCOA networks improves the quality of the information gathered, harmonizes data systems, and gives users valuable benefits, such as data interpretation.
The Diary Pte. Ltd, ICON PLC, PAREXEL INTERNATIONAL CORPORATION, Bracket Global LLC, Dassault Systèmes SE, and CRF Health are among the leading companies in the Middle East and Africa ePRO, ePatient Diaries, and eCOA market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in February 2021, ERT, announced a powerful new solution for enabling the collection, processing and analysis of photos and audio as part of clinical trial eCOA assessments. This solution promises to streamline and drive patient compliance with data collection, while safeguarding patient privacy, confidentiality, and data security.
The report segments the Middle East and Africa EPRO, ePatient Diaries, and eCOA market as follows:
By Type of Solution
- eClinical Outcome Assessments
- e-Patient Reported Outcomes
- Clinician Reported Outcomes
- Observer Reported Outcomes
- Performance Outcomes
- e-Patient Diaries
By Modality
- Computer
- Mobile Devices
By End User
- Clinical Trial Sponsors
- Contract Research Organizations
- Hospitals
- Academic Institutes
- Pharmaceutical Companies
- Others
By Country
- Middle East and Africa - UAE
- Saudi Arabia
- South Africa
- Rest of Middle East and Africa
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East and Africa ePRO, ePatient Diaries, and eCOA Market - Market Landscape
5. Middle East and Africa ePRO, ePatient Diaries, and eCOA Market - Key Market Dynamics
6. ePRO, ePatient Diaries, and eCOA Market - Middle East and Africa Analysis
7. Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Analysis and Forecasts To 2028 - By Type of Solution
8. Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Analysis and Forecasts To 2028 - By Modality
9. Middle East and Africa ePRO, ePatient Diaries, and eCOA Market Analysis and Forecasts to 2028- By End User
10. ePRO, ePatient Diaries, and eCOA Market Revenue and Forecasts to 2028 - Geographical Analysis
11. Impact Of COVID-19 Pandemic on Middle East and Africa ePRO, ePatient Diaries, and eCOA Market
12. Industry Landscape
13. Company Profiles
14. Appendix
List of Tables
List of Figures
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Some of the leading companies are:
- The Diary Pte. Ltd
- ICON PLC
- PAREXEL INTERNATIONAL CORPORATION
- Bracket Global LLC
- Dassault Systèmes SE
- CRF Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 119 |
| Published | June 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 48.4 Million |
| Forecasted Market Value ( USD | $ 112.3 Million |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Africa, Middle East |
![Global Electronic Clinical Outcome Assessment (eCOA) Solution Market by Modality (Wearable, Mobile, BYOD), Type (PRO, CLINRO, OBSRO, PERFO), Use ([Clinical trial: Onco, Rare, Mental Health], RWE, Registery), End-user, and Region - Forecast to 2029 - Product Image](http://www.researchandmarkets.com/product_images/12625/12625499_60px_jpg/global_electronic_clinical_outcome_assessment_solution_market.jpg)
